Ophthalmology Associates

St Louis, Missouri 63141

2 studies enrolling now · 55 studies all time

What they study most

Atopic Keratoconjunctivitis, Bacterial Conjunctivitis, Bacterial Infections, Blepharitis, Cataract, Cataract Extraction, Cataract Surgery, Cornea Preservation Time, Cornea Transplant, Corneal Diseases, Corneal Edema, Corneal Edema After Cataract Surgery

Studies at this site

• A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis — Recruiting now
• An Efficacy and Safety Study of DFL24498 in the Treatment of AKC — Recruiting now
• A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery — Completed
• Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus — Completed
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — Completed
• Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA) — Paused
• TearCare System to Treat Dry Eye Disease — Completed
• Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease — Stopped early
• to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction — Completed
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease — Completed
• STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma — Status unconfirmed
• A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED) — Status unconfirmed
• Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease — Completed
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye — Completed
• Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent — Completed
• A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery — Withdrawn before enrolling
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) — Status unconfirmed
• Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study — Completed
• A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery — Completed
• A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy — Completed
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) — Completed
• Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202) — Completed
• Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) — Completed
• Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas — Stopped early
• The DEPOT Study (Dry Eye Prescription Options for Therapy) — Completed
• Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis — Completed
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo — Completed
• Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery — Completed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation — Completed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes — Completed
• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome — Completed
• Post-Approval Study of the Tecnis® Toric IOL — Completed
• A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis — Completed
• A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease — Completed
• Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease — Stopped early
• Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis — Completed
• Cornea Preservation Time Study — Completed
• A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. — Completed
• A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction — Completed
• A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) — Completed
• A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma — Completed
• Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position — Completed
• Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty — Stopped early
• Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk — Stopped early